Clinical Trial Update: An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) [Phase 2]

View source ↗

Summary

An exploratory Phase 2 study of bedaquiline (TMC207) in Japanese patients with pulmonary multidrug-resistant tuberculosis has completed. The update provides the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2 | Status: COMPLETED